Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart Failure ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension.Eur Respir J. 2019; 53https://doi.org/10.1183/13993003.01913-2018
- Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.Eur Respir J. 2019; 53https://doi.org/10.1183/13993003.01887-2018
- Pulmonary arterial hypertension in connective tissue diseases.Heart Fail Clin. 2012; 8: 413-425
- ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.J Am Coll Cardiol. 2009; 53: 1573-1619
- Diagnosis of pulmonary hypertension.Eur Respir J. 2019; 53https://doi.org/10.1183/13993003.01904-2018
- Clinical trial design and new therapies for pulmonary arterial hypertension.Eur Respir J. 2019; 53https://doi.org/10.1183/13993003.01908-2018
- Pulmonary Hypertension Associated with Connective Tissue Disease.Semin Respir Crit Care Med. 2019; 40: 173-183
- REVEAL: a contemporary US pulmonary arterial hypertension registry.Eur Respir Rev. 2012; 21: 8-18
- Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.Int J Cardiol. 2017; 236: 432-437
- Pulmonary arterial hypertension in France: results from a national registry.Am J Respir Crit Care Med. 2006; 173: 1023-1030
- Geoepidemiology of systemic sclerosis.Autoimmun Rev Mar. 2010; 9: A311-A318
- Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry.BMC Pulm Med. 2014; 14: 45https://doi.org/10.1186/1471-2466-14-45
- Connective tissue associated pulmonary arterial hypertension.Lupus. 2006; 15: 138-142
- Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.Ann Rheum Dis. 2003; 62: 1088-1093
- Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies.J Rheumatol. 2010; 37: 2290-2298
- Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.Arthritis Rheum. 2005; 52: 3792-3800
- A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.Medicine (Baltimore). 1984; 63: 92-107
- Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.Arthritis Rheum. 1999; 42: 899-909
- Cardiovascular manifestations of mixed connective tissue disease in adults.Circulation. 1983; 68: 1182-1193
- Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature.Rheumatology (Oxford). 2013; 52: 1208-1213
- [Pulmonary arterial hypertension in systemic lupus erythematosus].Rev Med Interne. 2011; 32 (Hypertension arterielle pulmonaire associee au lupus systemique): 689-697
- Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy.Autoimmun Rev. 2013; 12: 410-415
- Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.Chest. 2010; 138: 1383-1394
- Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort.Rheumatology (Oxford). 2012; 51: 1846-1854
- Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.J Korean Med Sci. 2015; 30: 1429-1438
- Demographics, treatment trends, and survival rate in incident pulmonary artery hypertension in Korea: A nationwide study based on the health insurance review and assessment service database.PLoS One. 2018; 13: e0209148
- Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.Arthritis Res Ther. 2019; 21: 82
- Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality.Curr Rheumatol Rep. 2010; 12: 379-385
- The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study.Ann Rheum Dis. 2014; 73: 1316-1322
- Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry.Int J Rheum Dis. 2012; 15: e80-e89
- Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry.Respiration. 2018; 95: 244-250
- Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.Am J Respir Crit Care Med. 2009; 179: 151-157
- Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature.Medicine (Baltimore). 2007; 86: 299-315
- Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients.Eur Respir J. 2014; 44: 963-972
- Acute pulmonary arterial hypertension associated with anti-synthetase syndrome.Scand J Rheumatol. 2010; 39: 179-180
- Pulmonary hypertension in a case of dermatomyositis.J Rheumatol. 1993; 20: 1452-1453
- Pulmonary hypertension in polymyositis.Chest. 1981; 79: 105-107
- Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature. Medicine (Baltimore).Sep. 2016; 95: e4911
- Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry.Chest. 2018; 153: 143-151
- Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.Arthritis Rheum. 2011; 63: 3522-3530
- Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.Arthritis Rheum. 2013; 65: 2412-2423
- Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.Ann Rheum Dis. 2013; 72: 1940-1946
- Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis.Chest. 2003; 123: 344-350
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.Ann Rheum Dis. 2010; 69: 1809-1815
- Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.Ann Rheum Dis. 2014; 73: 1340-1349
- Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort.Eur Respir J. 2017; 49https://doi.org/10.1183/13993003.02275-2016
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).Eur Respir J. 2015; 46: 903-975
- Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects.Eur J Clin Invest. 2018; 48https://doi.org/10.1111/eci.12876
- Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus.Rheumatology (Oxford). 2009; 48: 1506-1511
- Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Prevalence and Predictors.J Rheumatol. 2016; 43: 323-329
- Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.Int J Rheum Dis. 2019; 22: 921-928
- Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study.ERJ Open Res. 2018; 4https://doi.org/10.1183/23120541.00135-2017
- Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.Ann Rheum Dis. 2017; 76: 1219-1227
- Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension.Eur Respir J. 2017; 50https://doi.org/10.1183/13993003.02493-2016
- Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials.Ann Rheum Dis. 2008; 67: 808-814
- Selexipag for the treatment of pulmonary arterial hypertension.Am J Health Syst Pharm. 2017; 74: 1135-1141
- Riociguat for the treatment of pulmonary arterial hypertension.N Engl J Med. 2013; 369: 330-340
- Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2).Eur Respir J. 2015; 45: 1303-1313
- Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.N Engl J Med. 2015; 373: 834-844
- Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.Arthritis Rheum. 2008; 58: 521-531
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
